 Study subjects will be asked to take Sulodexide twice a day. The Sulodexide will be taken in addition to the regular medications the subject is on. There will be no change in these other medications. The subject will also be asked to have blood tests each month to follow kidney function. The frequency of these tests is the normalstandard frequency for persons with MPGN IIDDD and is neither increased nor decreased because of participation in this study. The study will occur over 6 months for each subject. 